We are live on
!
Find out more
LS
Leelyn Smith Portfolio holdings
AUM
$822M
Turnover
11.52%
1-Year Est. Return
31.69%
This Fund
S&P 500
This Quarter
Est. Return
+16.11%
1 Year Est. Return
+31.69%
3 Year Est. Return
+77.34%
5 Year Est. Return
+91.98%
10 Year Est. Return
–
AUM
$243M
AUM Growth
+$55.2M
(+29%)
Cap. Flow
+$46.5M
Cap. Flow
% of AUM
19.17%
Top 10 Holdings %
Top 10 Hldgs %
43.97%
Holding
439
New
112
Increased
115
Reduced
72
Closed
39
Avg Time Held
0.3
years
Top 10 Avg Time Held
0.4
years
Top 20 Avg Time Held
0.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
3M
MMM
|
+$24.2M |
| 2 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$2.84M |
| 3 |
iShares MSCI USA Small-Cap Min Vol Factor ETF
SMMV
|
+$2.46M |
| 4 |
ExxonMobil
XOM
|
+$2.14M |
| 5 |
Vanguard Morningstar Mega Cap Growth ETF
MGK
|
+$1.48M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$2.22M |
| 2 |
Microsoft
MSFT
|
+$2.06M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.93M |
| 4 |
Blackrock
BLK
|
+$1.33M |
| 5 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$634K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 53.95% |
| 2 | Technology | 9.37% |
| 3 | Consumer Discretionary | 6.6% |
| 4 | Industrials | 5.97% |
| 5 | Consumer Staples | 5.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
226
VanEck Pharmaceutical ETF
PPH
$1.07B
| $15K | 0.01% |
245
| – | – |
2019 Q4
2 quarters
|
|
227
PayPal
PYPL
$48.9B
| $15K | 0.01% |
83
+60
| +261% | +$8.29K |
2019 Q4
2 quarters
|
|
228
First Trust US Equity Opportunities ETF
FPX
$1.41B
| $14K | 0.01% |
168
| – | – |
2019 Q4
2 quarters
|
|
229
Amgen
AMGN
$235B
| $13K | 0.01% |
57
+30
| +111% | +$6.84K |
2019 Q4
2 quarters
|
|
230
Baxter International
BAX
$13.3B
| $13K | 0.01% |
153
| – | – |
2019 Q4
2 quarters
|
|
231
Eaton Vance National Municipal Opportunities Trust
EOT
$241M
| $13K | 0.01% |
+650
| New | +$12.2K |
2020 Q2
0 quarters
|
|
232
iShares Core MSCI Europe ETF
IEUR
$9.31B
| $13K | 0.01% |
307
+50
| +19% | +$2.02K |
2020 Q1
1 quarter
|
|
233
ScottsMiracle-Gro
SMG
$3.16B
| $13K | 0.01% |
98
| – | – |
2019 Q4
2 quarters
|
|
234
Trane Technologies
TT
$101B
| $13K | 0.01% |
+150
| New | +$13K |
2020 Q2
0 quarters
|
|
235
US Bancorp
USB
$89.4B
| $13K | 0.01% |
354
-194
| -35% | -$6.91K |
2019 Q4
2 quarters
|
|
236
Vanguard Morningstar Small-Cap Value ETF
VBR
$36.1B
| $13K | 0.01% |
124
-2
| -2% | -$201 |
2019 Q4
2 quarters
|
|
237
Vanguard Real Estate ETF
VNQ
$36.7B
| $13K | 0.01% |
167
+2
| +1% | +$152 |
2019 Q4
2 quarters
|
|
238
ARK Innovation ETF
ARKK
$8.92B
| $12K | ﹤0.01% |
175
| – | – |
2020 Q1
1 quarter
|
|
239
Amplify Alternative Harvest ETF
MJ
$98.2M
| $12K | ﹤0.01% |
80
-16
| -17% | -$2.42K |
2019 Q4
2 quarters
|
|
240
Phillips 66
PSX
$115B
| $12K | ﹤0.01% |
161
+1
| +0.6% | +$71 |
2019 Q4
2 quarters
|
|
241
Arthur J. Gallagher & Co
AJG
$64.1B
| $11K | ﹤0.01% |
110
| – | – |
2019 Q4
2 quarters
|
|
242
NYLIM Merger Arbitrage ETF
MNA
$258M
| $11K | ﹤0.01% |
343
| – | – |
2019 Q4
2 quarters
|
|
243
NVIDIA
NVDA
$5.25T
| $11K | ﹤0.01% |
+1,120
| New | +$9.06K |
2020 Q2
0 quarters
|
|
244
DELISTED
Paramount Global Class B
PARA
| $11K | ﹤0.01% |
456
| – | – |
2020 Q1
1 quarter
|
|
245
iShares 20+ Year Treasury Bond ETF
TLT
$49.7B
| $11K | ﹤0.01% |
67
+2
| +3% | +$329 |
2019 Q4
2 quarters
|
|
246
State Street SPDR S&P China ETF
GXC
$445M
| $10K | ﹤0.01% |
99
-1
| -1% | -$98 |
2020 Q1
1 quarter
|
|
247
VanEck High Yield Muni ETF
HYD
$4.06B
| $10K | ﹤0.01% |
163
-7
| -4% | -$394 |
2020 Q1
1 quarter
|
|
248
Netflix
NFLX
$302B
| $10K | ﹤0.01% |
+210
| New | +$8.94K |
2020 Q2
0 quarters
|
|
249
Nuveen AMT-Free Municipal Credit Income Fund
NVG
$2.34B
| $10K | ﹤0.01% |
655
| – | – |
2020 Q1
1 quarter
|
|
250
Principal Financial Group
PFG
$23.3B
| $10K | ﹤0.01% |
234
| – | – |
2019 Q4
2 quarters
|
|
Similar funds
SCM
SCP
GSWM
HVIA
MGAM
IA
WRPWM
RP
Leelyn Smith's Q2 2020 Portfolio in Review
As of Q2 2020, Leelyn Smith held 439 positions worth $243M, up 29% from $187M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Leelyn Smith deployed $46.5M of net new capital in Q2 2020, opening 112 new positions and adding to 115 existing holdings. Its largest new stake was First Trust NYSE Arca Biotechnology Index Fund: 1,814 shares worth $304K.
By sector, the portfolio is most concentrated in Miscellaneous at 54% of assets, up from 53% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Clorox, an estimated $2.22M trimmed.
- Leelyn Smith's largest Q2 2020 buy was First Trust NYSE Arca Biotechnology Index Fund: 1,814 shares worth $304K.
- Leelyn Smith added most to 3M in Q2 2020, an estimated $24.2M increase.
- Leelyn Smith's biggest Q2 2020 reduction was Clorox, cutting an estimated $2.22M.
- Leelyn Smith fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q2 2020, selling an estimated $333K.
- Leelyn Smith's ten largest holdings make up 44% of its $243M portfolio in Q2 2020.
- Leelyn Smith opened 112 new positions and closed 39 in Q2 2020.
- Leelyn Smith's portfolio value rose 29% quarter-over-quarter to $243M.
Based on Leelyn Smith's 13F filing for Q2 2020, filed 6 Aug 2020.